Programmed Ribosomes
for Protein Synthesis
[
Discover RIBOHAIR™
]
A groundbreaking advancement
in quantum science impacting cell therapy.
Potential to be one of the leading cell therapy approaches.
Introducing
RiboHair
Ribosomes vs. programmed ribosomes
Programmed ribosomes take that natural process one step further. Instead of relying only on the body's default signaling, Ribodex technology is designed to guide ribosomes toward producing specific proteins and growth factors associated with targeted hair-follicle activity and regeneration.
In simple terms:
a ribosome is the factory; a programmed ribosome is the factory with a customized production plan. That's what makes Ribodex different it's not just adding another ingredient to the body, but using the body's own protein-making machinery in a more precise, purpose-driven way.
What are ribosomes?
Ribosomes are the body's natural protein factories. They read biological instructions and help cells make the proteins needed for normal growth, repair, and function.
Advanced therapeutic efficacy and minimum risk.
No Needles
Even complextion
Smoother texture
Enhanced firmness
Long-lasting hydration
Reduced sensitivity & redness
Improved clarity
Natural radiance
Clearer skin
Smaller pores
%
Efficacy tested.
[
CASE STUDIES
]
Before & After
Clinical case studies from our investigative physicians. Results shown after a four-treatment cycle.
CASE STUDY #01
Before
after
RiboHair™
CASE STUDY #02
Before
after
RiboHair™
CASE STUDY #03
Before
after
RiboHair™
CASE STUDY #04
Before
after
RiboHair™
CASE STUDY #05
Before
after
RiboHair™
CASE STUDY #06
Before
after
RiboHair™
CASE STUDY #07
Before
after
RiboHair™
CASE STUDY #08
Before
after
RiboHair™
[
THE PROTOCOL
]
Needle-free. Downtime-free. 30 minutes. That's it.
Clinical case studies from our investigative physicians. Results shown after a four-treatment cycle.
STARTER KIT · ONE-TIME
Everything needed to launch RiboHair treatments
Wholesale price to MedSpa, Salons, Barbershops ready to sell on day one
$3,700
STARTER KIT
The Ribohair Kit
What's included
Founder & CEO, Medolife Corporation (2007-present)
Inventor - programmed-ribosome technology (USPTO #18/467,595)
CSO - BioAlliance Holdings · Peptigenix · Ribodex
18+ years in peptide & molecular-delivery R&D
Juvasonic® Device
Sonic transdermal delivery · FDA-listed Class I
FDA Listed Needle-Free Serum Enhancement Technology Enhance topical absorption of cosmetic serums—without needles, pain, or compliance concerns. Juvasonic®️ uses medical-grade micro-dermabrasion and sonic vibration to temporarily disrupt the stratum corneum, allowing topical ingredients to absorb where they can work effectively.
Quantity: 1
Founder & CEO, Medolife Corporation (2007-present)
Inventor - programmed-ribosome technology (USPTO #18/467,595)
CSO - BioAlliance Holdings · Peptigenix · Ribodex
18+ years in peptide & molecular-delivery R&D
Juvasonic® cartridges
Sonic transdermal delivery · FDA-listed Class I
Single-Use Precision. Four Port Sizes. Enhances Topical Absorption. Designed exclusively for use with the Juvasonic®️ device, these sterile, single-use nano cartridges support enhanced topical absorption with precision-controlled serum flow. Available in four port sizes, each cartridge allows providers to match the tip to the viscosity of their selected cosmetic serum for a more controlled and efficient application.
Quantity: 12
Founder & CEO, Medolife Corporation (2007-present)
Inventor - programmed-ribosome technology (USPTO #18/467,595)
CSO - BioAlliance Holdings · Peptigenix · Ribodex
18+ years in peptide & molecular-delivery R&D
Dr. Pen® Microneedling Device
Ultima-M8 handpiece · adjustable depth
The benefits of cosmetic skin micro needling have been recognized for many years. Dr pen M8 uses Advanced Oscillating Vertical Needling technology with high-quality disposable tips.
Quantity: 1
Founder & CEO, Medolife Corporation (2007-present)
Inventor - programmed-ribosome technology (USPTO #18/467,595)
CSO - BioAlliance Holdings · Peptigenix · Ribodex
18+ years in peptide & molecular-delivery R&D
Dr. Pen® Cartridges
Ultima-M8 handpiece · adjustable depth
The Dr. Pen M8 cartridge uses ultra-thin surgical-grade stainless steel needles to safely trigger your skin's healing process. The needles pierce the skin to boost collagen, reduce wrinkles, smooth scars, and improve product absorption.
Quantity: 6
Founder & CEO, Medolife Corporation (2007-present)
Inventor - programmed-ribosome technology (USPTO #18/467,595)
CSO - BioAlliance Holdings · Peptigenix · Ribodex
18+ years in peptide & molecular-delivery R&D
RiboHair Serum Vials
Programmed Ribosomes
RiboHair™️ uses programmed ribosomal technology to support the natural production of key proteins and growth factors including Keratin, FGF-7, and VEGF within hair follicle cells. Keratin supports the hair's structural strength, FGF-7 helps stimulate and prolong the follicle's growth phase, and VEGF supports the blood vessel activity that nourishes growing hair, together promoting denser, fuller, and healthier-looking hair over time.
Quantity: 4
Founder & CEO, Medolife Corporation (2007-present)
Inventor - programmed-ribosome technology (USPTO #18/467,595)
CSO - BioAlliance Holdings · Peptigenix · Ribodex
18+ years in peptide & molecular-delivery R&D
Capilari Factor Vials
Support Scalp Microcirculation
Capillary Growth Factor is formulated to help support scalp microcirculation and prepare the scalp environment prior to RiboHair™️ application. By promoting healthy capillary function and optimizing local tissue perfusion, it is designed to facilitate the delivery of RiboHair™️ to the hair follicle region. The formulation also contains regenerative signaling factors that are widely studied for their role in supporting tissue repair, cellular communication, and the maintenance of a healthy scalp environment.
Quantity: 4
Founder & CEO, Medolife Corporation (2007-present)
Inventor - programmed-ribosome technology (USPTO #18/467,595)
CSO - BioAlliance Holdings · Peptigenix · Ribodex
18+ years in peptide & molecular-delivery R&D
Lidocaine Vial
local anesthetic
Lidocaine is a powerful local anesthetic that works by temporarily blocking nerve signals in your body.
Quantity: 1
[
THE TEAM
]
The Science Team
Clinical case studies from our investigative physicians. Results shown after a four-treatment cycle.
Founder & CEO, Medolife Corporation (2007-present)
Inventor - programmed-ribosome technology (USPTO #18/467,595)
CSO - BioAlliance Holdings · Peptigenix · Ribodex
18+ years in peptide & molecular-delivery R&D
Dr. Arthur Mikaelian
CO-FOUNDER & INVENTOR
Inventor of RIBODEX's programmed-ribosome technology and a biotechnology founder with nearly two decades building peptide and molecular-delivery research programs. As Founder & CEO of Medolife Corporation (2007-present), he has led peptide-based therapeutic research across oncology and related fields, built international research partnerships, and directed programs tied to patented and patent-pending molecular-delivery technologies. He is also founder of Mikaelian Resonance Technology and serves as Chief Scientific Officer across BioAlliance Holdings, Peptigenix LLC, and Ribodex LLC.
20+ Years Surgical Experience
Regenerative Medicine Expert
Founder of Advanced Nasal Therapies
Founder of Advanced Nasal Therapies
Dr. Gonzalo Jimenez-Orcí
INVESTIGATIVE PHYSICIAN & CLINICAL ADVISOR
A physician and regenerative-medicine researcher with 15+ years in stem-cell and exosome clinical research, a pioneer of stem-cell therapy clinical research in Mexico. Board-certified in Otolaryngology, on staff at Angeles Hospital, Tijuana; member of the College and Council of Regenerative Medicine and Cellular Therapy in Mexico; on the hospital IRB since 2008; clinical-trial administrator trained through UC San Diego (2012). Currently Chief Medical Director, Immunotherapy Wellness Center, Tijuana. 2019 Leadership Award.
PhD, Cell & Developmental Biology - Vanderbilt
Founder, Mighty Ventures (translational life sciences)
Former CSO, Tikun Olam USA · Board Director, Flora Growth (Nasdaq)
NIH clinical-trial certified · Congressional recognition
Dr. Annabelle Manalo-Morgan, PhD
SCIENTIFIC ADVISOR & INVESTIGATIVE RESEARCHER
A cell and developmental biologist and translational-medicine founder, serving as a Scientific Advisor and investigative researcher on RIBODEX's programmed-ribosome technology. PhD in Cell & Developmental Biology from Vanderbilt (cardiac development / chemotherapy cardiotoxicity); graduate training in neuroscience at Georgetown; NIH clinical-trial certified. Founder of Mighty Ventures; former CSO of Tikun Olam USA; Board Director & Lead Scientific Officer of Nasdaq-listed Flora Growth Corp. Launching NFL-concussion and women's-fertility trials Q1 2026. Recognized by the U.S. Congress for a scientific breakthrough; ForbesBooks bestselling author (Mighty Flower, 2023).
Hair Surgeon & Trichologist
Aesthetic Medicine Doctor
Hair Restoration Specialist
Founder, Procapelli Clinic
Dr. Danessa Zini
SCIENTIFIC ADVISOR & INVESTIGATIVE RESEARCHER
Dr. Zini: observed activation of dormant follicles and stimulation of existing hair in her cases, as early as two weeks (image clearance pending). “RiboHair is a more targeted and simpler procedure with faster results. Does not require blood extraction or handling, which reduces stress and anxiety in patients.” - Dr. Danessa Zini
Micro & Cellular Biologist
Programmed-Ribosome Researcher
Scientific Testing Lead